Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 42, Issue 2 (Feb 2004)

Issues

Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?

Corinne Charlier / Jean-Michel Foidart / François Pitance / Philippe Herman / Ulysse Gaspard / Michel Meurisse / Guy Plomteux
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.040

Abstract

The carcinogenic potential of environmental xenoestrogens (i.e., organochlorines) is a matter of controversy. Their pathogenic role as promoters in breast cancer has been previously suggested. In Europe, despite their prohibition since the ’70s, residues persist in soil and rivers resulting in a widespread contamination of the general population. In this study, we have compared the serum levels of p,p'-1,1-dichloro-2, 2-bis (4-chlorophenyl) ethylene (DDE) and hexachlorobenzene (HCB) in 231 women at the time of breast cancer discovery and in 290 age-matched healthy controls. p,p'-DDE was found in 76.2% of cases and in 71.1% of controls but HCB was present only in 12.6% of cases (29 from 231) and in 8.9% of controls (26 from 290). Even if taking all undetectable results (recorded as “0”) into consideration, mean values were significantly different in cases when compared to controls. The serum level of p,p'-DDE was 3.46±3.48 ppb (0.58±0.58 μg/g lipid) in patients and 1.85±2.09 ppb (0.31±0.35 μg/g lipid) in controls (p<0.0001). The HCB serum level was 0.66±1.25 ppb (0.11±0.21 μg/g lipid) in patients and 0.20±1.02 ppb (0.03±0.17 μg/g lipid) in controls (p<0.0001). When considering p,p'-DDE and HCB as binary variables (1 if higher than the limit of quantification, 0 if lower), the presence of both residues was significantly associated with an increased risk of breast cancer development (OR 2.21, 95% CI 1.41–3.48 for p,p'-DDE and OR 4.99, 95% CI 2.95–8.43 for HCB). No excess was observed among parous women or when familial history of breast cancer was considered. In the cancer group, no differences in serum levels of p,p'-DDE or HCB were found in relation with estrogen-receptor (ER) status, Bloom stage or lymph node metastasis, but the HCB level was moderately correlated with tumor size (p=0.026).

About the article

Published Online: 2005-06-01

Published in Print: 2004-02-18



Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.040. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Kyungsil Yoon, Seung Jun Kwack, Hyung Sik Kim, and Byung-Mu Lee
Journal of Toxicology and Environmental Health, Part B, 2014, Volume 17, Number 3, Page 127
[2]
Jae-Hong Park, Eun Shil Cha, Yousun Ko, Myung-Sil Hwang, Jin-Hwan Hong, and Won Jin Lee
Osong Public Health and Research Perspectives, 2014, Volume 5, Number 2, Page 77
[3]
Beata Pepłońska, Weronika Burdelak, Agnieszka Bukowska, Jolanta Krysicka, and Katarzyna Konieczko
International Journal of Occupational Medicine and Environmental Health, 2013, Volume 26, Number 4
[4]
NARGES KHANJANI, JAN LUCAS HOVING, ANDREW BENJAMIN FORBES, and MALCOLM ROSS SIM
Journal of Environmental Science and Health, Part C, 2007, Volume 25, Number 1, Page 23
[5]
Nakpangi A Johnson, Arline Ho, J. Mark Cline, Claude L Hughes, Warren G Foster, and Vicki L Davis
Environmental Health Perspectives, 2012, Volume 120, Number 8, Page 1170
[6]
Walter J Rogan and Aimin Chen
The Lancet, 2005, Volume 366, Number 9487, Page 763
[8]
Hiroyoshi Toyoshiba, Hiroshi Sawada, Ichiro Naeshiro, and Akira Horinouchi
Toxicology Letters, 2009, Volume 186, Number 1, Page 52
[9]
Kushik Jaga and Chandrabhan Dharmani
Reviews on Environmental Health, 2005, Volume 20, Number 1
[10]
Brenda Eskenazi, Jonathan Chevrier, Lisa Goldman Rosas, Henry A. Anderson, Maria S. Bornman, Henk Bouwman, Aimin Chen, Barbara A. Cohn, Christiaan de Jager, Diane S. Henshel, Felicia Leipzig, John S. Leipzig, Edward C. Lorenz, Suzanne M. Snedeker, and Darwin Stapleton
Environmental Health Perspectives, 2009, Volume 117, Number 9, Page 1359
[11]
Hiroaki Itoh, Motoki Iwasaki, Tomoyuki Hanaoka, Yoshio Kasuga, Shiro Yokoyama, Hiroshi Onuma, Hideki Nishimura, Ritsu Kusama, and Shoichiro Tsugane
Cancer Causes & Control, 2009, Volume 20, Number 5, Page 567
[12]
Toshio Ichihara, Norio Imai, Yosuke Toda, Akihiro Hagiwara, Seiko Tamano, and Tomoyuki Shirai
Journal of Toxicologic Pathology, 2005, Volume 18, Number 1, Page 7
[13]
Julia Green Brody, Kirsten B. Moysich, Olivier Humblet, Kathleen R. Attfield, Gregory P. Beehler, and Ruthann A. Rudel
Cancer, 2007, Volume 109, Number S12, Page 2667

Comments (0)

Please log in or register to comment.
Log in